Search Drug Information, Interactions, Images, Dosage & Side Effects | MIMS.com Philippines

News & CME

- - Original New Drug Application Approvals by US FDA (15 - 28 Feb)
  - Mar 2015
  - New drug applications approved by US FDA as of 15 - 28 Feb 2015 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative ...
- - Itchy nasties common in childhood
  - Mar 2015
  - School-aged children are susceptible to unpleasant infections from a number of parasites, including head lice, worms and scabies.
- - Easy ear care advice for patients
  - Mar 2015
  - As health professionals, pharmacists are in a position to give important advice to patients dealing with ear infections.

More

Drug Updates

New Molecules

Azilect	Eylea
Xeljanz

New Indications

New Presentations

2-Gen	Escivex 5/Escive...
Glimesyn	Kenzar
Valazyd

Question Of The Month

Which of the following topics associated with diabetes, obesity and CVD are you most interested to learn about?

survey

Please wait...

New Product Highlight

More

Featured Events

East Meets West
Hong Kong Diabetes & Cardiovascular Risk Factors – East Meets West (EMW) Symposium

GWICC & APHC 2014
The 25th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress 2014

ISRD
International Symposium of Respiratory Diseases

APSR
19th Congress of Asia Pacific Society of Respirology

APCMFM
10th Asia Pacific Congress in Maternal Fetal Medicine

PCCP
PCCP 2014 Midyear Convention: State of the Art Pulmonology (Convergence of Practice)

AOCE
Linking Endocrine and Diabetes Endeavors in the Region (LEADER)

Browse MIMS.com

Drugs

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

#

Companies

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

#

Resources

Medical Calculators
Useful Clinical Calculators

MIMS Subscription
Subscribe to MIMS publications

MIMS Video Series
Interviews with leading experts

Useful Links
Links to other medical websites

Download FREE MIMS Apps

Connect With Us

Node#1